How to Taper Off Semaglutide Safely

The Wegovy injection prescribing information describes starting treatment, increasing doses and handling missed doses. It does not supply an FDA-labeled taper for discontinuation. A chart that reverses the starting schedule may look tidy, but that does not make it a validated stopping protocol. There is no universal percentage reduction or number of weeks that every patient should follow.

The absence of a labeled taper does not mean your concerns about stopping are unimportant. Appetite, weight maintenance, blood sugar, side effects and the reason for stopping all deserve review. Your clinician may discuss a personalized step-down, continued maintenance or stopping without a staged reduction, depending on the circumstances. The Wegovy label is brand reference information, not a compounded prescription.

Wilding and colleagues reported the STEP 1 extension in Diabetes, Obesity and Metabolism in 2022. The exploratory extension followed 327 participants after the 68-week treatment period. Participants in the semaglutide group had received the branded injectable semaglutide 2.4-mg regimen associated with Wegovy, alongside lifestyle intervention. Both medication and the study lifestyle intervention ended at week 68.

The published abstract reports the following results. These findings describe stopping treatment, not a comparison of tapering with abrupt withdrawal.

Participants regained approximately two-thirds of their prior weight loss over the year after withdrawal. Many cardiometabolic improvements moved back toward baseline. This was an exploratory follow-up subset, and the structured lifestyle intervention also stopped, so it cannot isolate how a different maintenance program would perform. It also does not establish that a gradual taper prevents regain. The study did not test compounded medication or Join Luma patient outcomes.

Tell your clinician why you want to stop: cost, side effects, pregnancy planning, personal preference, a change in health or reaching your goal. Ask what ongoing maintenance could look like and what alternatives are appropriate. A medication decision should fit the reason for the change rather than force every situation into the same step-down chart.

• Share your current dose in milligrams and the date of your last injection.
• List other medicines, especially diabetes treatments, and recent health changes.
• Describe appetite, nutrition, weight trend and side effects.
• Agree on follow-up and what would prompt reconsidering the plan.

Pregnancy planning requires its own discussion: the cited Wegovy label advises discontinuation at least two months before a planned pregnancy because of semaglutide’s long half-life. Do not use a generic taper plan instead of that conversation. If you become pregnant, contact your clinician promptly about treatment.

A clinician considering a step-down may review whether lower exposure is likely to preserve benefit while improving tolerability or meeting your goals. They can specify the actual dose, how long to stay there, monitoring and when to check in. Such a plan is individualized clinical judgment, not an FDA-approved semaglutide taper or a proven way to eliminate weight regain.

Ask for directions that distinguish medication amount from injection volume. If a new concentration or vial is prescribed, old syringe markings may not apply. Do not assume that halving the visible syringe amount is the correct next step. The mg, mL and units guide explains the vocabulary, but your clinician or pharmacy must confirm the numbers on your prescription.

Spacing injections farther apart is also a medication change. Do not create an extended-interval schedule yourself to use up a vial or reduce cost. Your clinician should decide whether an interval change, dose change or another plan is appropriate.

Start the maintenance plan before the final injection when possible. Build a meal routine that still works when hunger is stronger: regular meals, protein-containing foods and fiber-rich choices you tolerate. Keep practical options available for busy days. Severe restriction may feel manageable while appetite is low but become difficult to sustain when medication effects fade.

Include resistance exercise suited to your health and mobility, along with routine movement you enjoy. Muscle strength, physical function and adequate nutrition matter even if your weight remains stable. Ask for individualized targets if you have medical conditions affecting protein intake, exercise or fluid needs. The protein calculator is a discussion tool rather than a medical prescription.

Set up a simple monitoring routine. If you weigh yourself, compare similar conditions and review a multiweek trend. Also note appetite, energy, sleep and how meals are going. Agree on a point for contacting the clinician rather than waiting for a large regain. NIDDK’s overview emphasizes that weight-management medication works alongside habits and may be needed long term.

The FDA-approved brand injection schedules discussed here are reference information, not a prescription for a compounded formulation. Join Luma offers compounded medications, which are not FDA-approved and were not the products studied in brand clinical trials. Their dose, concentration, directions and beyond-use date must come from your own prescription label and clinician. The FDA explains these distinctions.

For a compounded vial, the pharmacy label determines concentration, directions and beyond-use date. A brand pen’s storage allowance cannot be applied to your vial. Never self-adjust syringe units, draw extra doses or keep using a vial beyond its labeled instructions because you are reducing the amount injected. Ask the pharmacy or clinician before using medication after a storage concern.

Your Join Luma clinician sets any treatment changes. If cost is the concern, discuss plan options and remember that Join Luma uses the same price every dose. A smaller dose does not automatically lower the plan price. Contact support about billing logistics separately from requesting a medical stopping plan.

Returning hunger is a reason to use your agreed maintenance plan and seek support, not a personal failure. Contact your clinician if maintaining nutrition feels difficult, weight trends upward or you want to discuss medication again. Restarting may require reassessment and a lower starting step after a gap; do not return to the previous dose automatically.

Bring the stop date, previous dose, reason for stopping and any health changes to the review. If considering another medication, the switching guide explains why there is no simple dose exchange. Support@joinluma.com and the patient portal can help route routine questions, but your clinician makes prescribing decisions.

Seek urgent care for severe or persistent abdominal pain, repeated vomiting with dehydration, or other severe symptoms. Call 911 for trouble breathing, swelling of the face or throat, or another potentially life-threatening allergic reaction. Routine scheduling questions belong with your clinician, but serious symptoms should not wait for a portal reply. Tell the clinician about pregnancy plans, diabetes medicines and planned procedures before making treatment changes.